EUVIMEDEUVIMED entdecken
Crossref

Inosine attenuates rotenone‐induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis

Aya M Abd El-Latif, Mostafa A Rabie iD, Rabab H Sayed iD, Mai A Abd El Fattah, Sanaa A Kenawy

Drug Development Research · 2023

DOI: 10.1002/ddr.22077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Aya M Abd El-Latif und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence points to impaired autophagy as one of the major factors implicated in the pathophysiology of Parkinson's disease (PD). Autophagy is a downstream target of adenosine monophosphate‐activated protein kinase (AMPK). Inosine has already demonstrated a neuroprotective effect against neuronal loss in neurodegenerative diseases, mainly due its anti‐inflammatory and antioxidant properties. We, herein, aimed at investigating the neuroprotective effects of inosine against rotenone‐induced PD in rats and to focus on the activation of AMPK‐mediated autophagy. Inosine successfully increased p‐AMPK/AMPK ratio in PD rats and improved their motor performance and muscular co‐ordination (assessed by rotarod, open field, and grip strength tests, as well as by manual gait analysis). Furthermore, inosine was able to mitigate the rotenone‐induced histopathological alterations and to restore the tyrosine hydroxylase immunoreactivity in PD rats' substantia nigra. Inosine‐induced AMPK activation resulted in an autophagy enhancement, as demonstrated by the increased striatal Unc‐S1‐like kinase1 and beclin‐1 expression, and also by the increment light chain 3II to light chain 3I ratio, along with the decline in striatal mammalian target of rapamycin and p62 protein expressions. The inosine‐induced stimulation of AMPK also attenuated neuronal apoptosis and promoted antioxidant activity. Unsurprisingly, these neuroprotective effects were antagonized by a preadministration of dorsomorphin (an AMPK inhibitor). In conclusion, inosine exerted neuroprotective effects against the rotenone‐induced neuronal loss via an AMPK activation and through the restoration of the imbalance between autophagy and apoptosis. These findings support potential application of inosine in PD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeuroprotective AgentsRatsAnimalsRotenoneAMP-Activated Protein KinasesApoptosisAntioxidantsAutophagyMammals

Stichwörter der Autor:innen

AMPKInosineParkinson's diseaseapoptosisautophagysubstantia nigra

Substanzen

RotenoneNeuroprotective AgentsAMP-Activated Protein KinasesAntioxidants

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

ORCID-Profile: Mostafa A Rabie, Rabab H Sayed

Zitieren

APA

El-Latif, A. M. A., Rabie, M. A., Sayed, R. H., Fattah, M. A. A. E., & Kenawy, S. A. (2023). Inosine attenuates rotenone‐induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis. Drug Development Research. https://doi.org/10.1002/ddr.22077

Vancouver

El-Latif AMA, Rabie MA, Sayed RH, Fattah MAAE, Kenawy SA. Inosine attenuates rotenone‐induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis. Drug Development Research. 2023. doi:10.1002/ddr.22077

BibTeX
@article{ElLatif2023,
  author = {El-Latif, Aya M Abd and Rabie, Mostafa A and Sayed, Rabab H and Fattah, Mai A Abd El and Kenawy, Sanaa A},
  title = {Inosine attenuates rotenone‐induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22077}
}
Kostenlos starten →